AF
NKTR icon

Advisornet Financial’s Nektar Therapeutics NKTR Stock Holding History

Advisornet Financial’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,333
Closed -$600K – 1963
2021
Q2 		$600K Sell
2,333
-334
-13% -$92.4K 0.04% 355
2021
Q1 		$800K Sell
2,667
-1,666
-38% -$519K 0.06% 285
2020
Q4 		$1.1M Buy
4,333
+2,213
+104% +$572K 0.09% 204
2020
Q3 		$528K Buy
2,120
+120
+6% +$37.7K 0.05% 332
2020
Q2 		$695K Hold
2,000
– – 0.06% 274
2020
Q1 		$536K Buy
2,000
+1,767
+758% +$547K 0.05% 291
2019
Q4 		$77K Buy
233
+133
+133% +$38.6K 0.01% 758
2019
Q3 		$27K Buy
100
+33
+49% +$12.1K ﹤0.01% 1104
2019
Q2 		$36K Buy
+67
New +$33.6K ﹤0.01% 908

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Advisornet Financial's NKTR Position: Q3 2021 in Review

Advisornet Financial sold out of Nektar Therapeutics (NKTR) in Q3 2021, closing a stake of 11,381 shares — an estimated $2.93M sold.

Advisornet Financial first reported a position in NKTR in Q4 2017 and held it in 15 quarters. The position peaked at $3.94M in Q3 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q3 2021.

  • Advisornet Financial reported no remaining Nektar Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Advisornet Financial sold 11,381 Nektar Therapeutics shares in Q3 2021, an estimated $2.93M.
  • Advisornet Financial first reported a position in Nektar Therapeutics in Q4 2017 and held it in 15 quarters.
  • Advisornet Financial's Nektar Therapeutics position peaked at $3.94M in Q3 2018.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2021.

Based on Advisornet Financial's 13F filing for Q3 2021, filed 15 Oct 2021.